Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-25 @ 5:20 PM
Study NCT ID:
NCT03558503
Status:
COMPLETED
Last Update Posted:
2022-09-16
First Post:
2018-05-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
Sponsor:
UroGen Pharma Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-21
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-08
First Submit QC Date:
None
Study First Post Date:
2018-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-06-29
Results First Submit QC Date:
None
Results First Post Date:
2022-07-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-12-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-09-01
Last Update Post Date:
2022-09-16
Last Update Post Date Type:
ACTUAL